New approaches in the pharmacologic treatment of portal hypertension. (Q40709930)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

review article

1 reference

title

New approaches in the pharmacologic treatment of portal hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

author name string

J Bosch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

J C García-Pagán

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

F Feu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

A Luca

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

P Pizcueta

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

J Rodés

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

volume

17 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

S41-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

Portal pressure, presence of gastroesophageal varices and variceal bleeding

24 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: comparison with the effects on portal pressure

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multic

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Short-term effects of propranolol on portal venous pressure

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis. Pharmacokinetic-hemodynamic interactions

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Effect and mechanism of action of isosorbide-5-mononitrate

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Hemodynamic evaluation of molsidomine: a vasodilator with antianginal properties in patients with alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

ICI 169,369 selectively blocks 5-hydroxytryptamine2 receptors and lowers portal pressure in portal hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanisms in portal hypertension

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Long-term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

SYMPATHETIC TONE MODULATES PORTAL VENOUS PRESSURE IN ALCOHOLIC CIRRHOSIS

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Hemodynamic effects of a clonidine-induced decrease in sympathetic tone in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Oral administration of clonidine in patients with alcoholic cirrhosis. Hemodynamic and liver function effects

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect

1 reference

https://api.crossref.org/works/10.1016/S0168-8278(05)80455-6

7 January 2021

10.1016/S0168-8278(05)80455-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8098342 AND SRC:MED&resulttype=core&format=json

24 October 2019

1 reference